Amyotrophic lateral sclerosis (Q41053): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A esclerose lateral amiotrófica (ELA) é um transtorno progressivo e fatal em que sinais progressivos de NMI e degeneração NMS são vistos em uma ou mais das quatro regiões: bulbar, cervical, torácica e lombossacra. Estudos eletrofisiológicos podem ser necessários para confirmar a degeneração do neurônio motor inferior e para excluir causas alternativas. A neuroimagem pode ser realizada para excluir outras causas, o que pode explicar as características clínicas e eletrofisiológicas. ELA familiar de herança autossômica dominante, constitui 5 a 10% de ALS. O perfil clínico de ELA familiar e ELA esporádico é semelhante. Mutações nos genes C9ORF72 e SOD1 (mutação da enzima Cu,Zn-superóxido dismutase) constituem 50-60% dos casos de ELA familiar.
description / endescription / en
 
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder in which progressive signs of LMN and UMN degeneration are seen within one or more of the four regions: bulbar, cervical, thoracic and lumbosacral. Electrophysiological studies may be required to confirm lower motor neuron degeneration and to exclude alternative causes. Neuroimaging may be performed to exclude other causes, which might explain the clinical and electrophysiological features. Familial ALS (FALS) of autosomal dominant inheritance constitutes 5 to 10% of ALS. The clinical profile of FALS and sporadic ALS is similar. Mutations in the C9ORF72 and Cu/Zn superoxide dismutase (SOD1) genes constitute 50-60% of FALS.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1982355687 / rank
 
Normal rank
Property / CURIE
 
CID11:8B60.0
Property / CURIE: CID11:8B60.0 / rank
 
Normal rank
Property / Canary Token
 
dki-india-8B60.0
Property / Canary Token: dki-india-8B60.0 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: G12.2 / rank
 
Normal rank

Latest revision as of 07:06, 13 August 2026

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder in which progressive signs of LMN and UMN degeneration are seen within one or more of the four regions: bulbar, cervical, thoracic and lumbosacral. Electrophysiological studies may be required to confirm lower motor neuron degeneration and to exclude alternative causes. Neuroimaging may be performed to exclude other causes, which might explain the clinical and electrophysiological features. Familial ALS (FALS) of autosomal dominant inheritance constitutes 5 to 10% of ALS. The clinical profile of FALS and sporadic ALS is similar. Mutations in the C9ORF72 and Cu/Zn superoxide dismutase (SOD1) genes constitute 50-60% of FALS.
Language Label Description Also known as
default for all languages
8B60.0
    English
    Amyotrophic lateral sclerosis
    Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder in which progressive signs of LMN and UMN degeneration are seen within one or more of the four regions: bulbar, cervical, thoracic and lumbosacral. Electrophysiological studies may be required to confirm lower motor neuron degeneration and to exclude alternative causes. Neuroimaging may be performed to exclude other causes, which might explain the clinical and electrophysiological features. Familial ALS (FALS) of autosomal dominant inheritance constitutes 5 to 10% of ALS. The clinical profile of FALS and sporadic ALS is similar. Mutations in the C9ORF72 and Cu/Zn superoxide dismutase (SOD1) genes constitute 50-60% of FALS.

      Statements

      CID11:8B60.0
      0 references
      dki-india-8B60.0
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references